Sandu Pharmaceuticals Ltd To Hold Board Meeting to Discuss FY26 Financial Results
Sandu Pharmaceuticals Ltd announced that a Board Meeting of the Company’s Directors is scheduled for Tuesday, May 5, 2026. The meeting is set to take place at 03:00 p.m. at the Corporate Office of the Company, located at Sandu Pharmaceuticals Limited, Sandu Nagar, D K Sandu Marg, Chembur, Mumbai 400 071.The primary agenda items for the Board include considering the financial performance and making recommendations regarding the fiscal year 2026.
During the meeting, the directors are expected to address the following matters:
- Approval of the Standalone Audited Financial Results of the Company for the Quarter and the entire year ended March 31, 2026.
- Consideration and recommendation of a Final Dividend, if any, for the Financial Year ended March 31, 2026.
- Any other business with the permission of the Chairman.
In addition to the meeting announcement, the company provided an update regarding its internal trading guidelines. Sandu Pharmaceuticals noted that the trading window for the Company’s Directors, Officers, and designated employees has been closed. This restriction was effective from the opening of trading hours on Wednesday, April 1, 2026, and will remain closed until 48 hours following the announcement of the financial results for the Quarter and year ended March 31, 2026.
Stock Price Movement
As of 15:25, Sandu Pharmaceuticals Ltd shares are ticking up to ₹46.80, gaining 6.85% in today's trading session. Throughout the day, the stock moved through a significant range, trading between a low of ₹42.10 and a high of ₹50.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.